Your browser doesn't support javascript.
loading
BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications.
Bae, Jooeun; Parayath, Neha; Ma, Wenxue; Amiji, Mansoor; Munshi, Nikhil; Anderson, Kenneth C.
Affiliation
  • Bae J; Dana-Farber Cancer Institute, Boston, MA, USA. jooeun_bae@dfci.harvard.edu.
  • Parayath N; Harvard Medical School, Boston, MA, USA. jooeun_bae@dfci.harvard.edu.
  • Ma W; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Amiji M; University of California San Diego, San Diego, CA, USA.
  • Munshi N; Northeastern University, Boston, MA, USA.
  • Anderson KC; Dana-Farber Cancer Institute, Boston, MA, USA.
Leukemia ; 34(1): 210-223, 2020 01.
Article in En | MEDLINE | ID: mdl-31427721
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / Cancer Vaccines / B-Cell Maturation Antigen / Nanoparticles / Multiple Myeloma Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / Cancer Vaccines / B-Cell Maturation Antigen / Nanoparticles / Multiple Myeloma Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication: